Advanced Enzyme Tech receives promoter group reclassification requests

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Four promoter group members requested reclassification to public category
  • Applicants hold nil equity shares in Advanced Enzyme Technologies Ltd
  • Requests submitted under Regulation 31A of SEBI LODR Regulations
  • Approval from Board of Directors and stock exchanges is required
powered bylight_fuzz_icon
51194970

*this image is generated using AI for illustrative purposes only.

Advanced Enzyme Technologies Ltd received revised requests on September 17, 2026, from four promoter group members seeking reclassification to the public category. The move follows an earlier intimation issued by the company on September 5, 2026.

The requests were submitted under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The applicants include Savita Chandrakumar Rathi, Piyush Chandrakumar Rathi, Advenza Global Limited, and Atharva Green Ecotech LLP.

Shareholding Details

All four entities currently hold nil equity shares in the company. The table below outlines the current shareholding status of the requesting parties.

Entity Name Current Category Equity Shares Held
Savita Chandrakumar Rathi Promoter Group NIL
Piyush Chandrakumar Rathi Promoter Group NIL
Advenza Global Limited Promoter Group NIL
Atharva Green Ecotech LLP Promoter Group NIL

Regulatory Compliance

Each applicant declared that they do not hold any voting rights or exercise control over the company’s affairs. They also confirmed non-involvement in management, absence of special rights, and no representation on the Board of Directors or as Key Managerial Personnel.

The applicants further stated they are not persons acting in concert with existing promoters, nor are they wilful defaulters or fugitive economic offenders. The reclassification is subject to approval by the Board of Directors and stock exchanges.

Historical Stock Returns for Advanced Enzyme Tech

1 Day5 Days1 Month6 Months1 Year5 Years
+0.09%-3.81%-5.32%+4.59%-16.53%-26.17%

What strategic rationale drives the promoter group members to seek reclassification to the public category despite currently holding zero equity shares?

How might this reclassification impact the company's future shareholding pattern disclosures and regulatory reporting obligations under SEBI norms?

Does this move signal an impending restructuring of the promoter group or potential divestment plans for entities like Advenza Global Limited and Atharva Green Ecotech LLP?

Advanced Enzyme Tech buys 56,066 shares on Sep 17 at avg ₹289.48

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Advanced Enzyme Technologies repurchased 56,066 shares on September 17, 2026
  • The average acquisition price was ₹289.48 on the National Stock Exchange
  • Cumulative shares bought back have risen to 13,53,488
  • Transactions were facilitated by Emkay Global Financial Services Limited
  • No closed-out quantities were reported for the day
powered bylight_fuzz_icon
48014513

*this image is generated using AI for illustrative purposes only.

Advanced Enzyme Technologies Limited repurchased 56,066 equity shares on September 17, 2026, continuing its open market buyback program. The average acquisition price for the day was ₹289.48.

Emkay Global Financial Services Limited, the Manager to the Buyback, facilitated these transactions exclusively on the National Stock Exchange (NSE). No transactions were reported on the Bombay Stock Exchange (BSE) or Mumbai Stock Exchange (MSEI). There were no closed-out quantities reported for the day.

Daily Buyback Report (Sep 17)

The daily report submitted to the stock exchanges confirms active acquisition for the day.

Metric Details
Shares Bought Back (Sep 17) 56,066
Average Acquisition Price ₹289.48
Exchange NSE
Broker Emkay Global Financial Services Limited
Cumulative Shares Bought Back 13,53,488

Buyback Progress Update

As of September 17, 2026, the cumulative number of equity shares bought back stood at 13,53,488. This is an increase from the previous cumulative total of 12,97,422 shares reported as of September 16, 2026. This progress moves the company closer to its initial deployment target of ₹278,800,000, which must be utilized within the first half of the offer period. The total quantity closed out remains at zero.

Buyback Offer Parameters

The buyback targets up to 1,394,000 equity shares, constituting approximately 1.24% of the total paid-up equity share capital as of August 8, 2026. The maximum buyback size is ₹697,000,000, funded entirely from free reserves and internal accruals with no borrowed funds utilized.

Parameter Details
Maximum Buyback Size ₹697,000,000
Maximum Buyback Price ₹500 per Equity Share
Maximum Buyback Shares 1,394,000
Minimum Buyback Size (75%) ₹522,750,000
Initial Deployment (40%) ₹278,800,000
Face Value ₹2/- each
Method Open market through stock exchanges
Source of Funds Free reserves and internal accruals

The company is required to utilize at least 75% of the Maximum Buyback Size, i.e., ₹522,750,000. Furthermore, at least 40% of the Buyback Size, i.e., ₹278,800,000, must be deployed within the initial half of the Offer Period. The buyback offer is expected to open on or before August 14, 2026, and close no later than November 20, 2026, being sixty-six Working Days from the opening date.

Premium and Market Context

The Maximum Buyback Price of ₹500 carries a substantial premium over recent market benchmarks. On August 8, 2026, the closing market price was ₹324.40 on BSE and ₹324.35 on NSE. The acquisition price of ₹289.48 on September 17 remains well below the maximum ceiling.

Benchmark Period Premium on BSE Premium on NSE
3-month VWAP (prior to Aug 1, 2026) 42.42% 42.43%
2-week VWAP (prior to Aug 1, 2026) 58.95% 58.88%
1-month VWAP (prior to Aug 1, 2026) 56.62% 56.63%
Closing price (Aug 1, 2026) 58.73% 58.68%

This premium reflects management’s confidence in the intrinsic value of the shares and serves as a strong signal to investors regarding the company’s financial health and future prospects.

Capital Structure Impact

If the full Maximum Buyback Size is utilized at the Maximum Buyback Price, the issued, subscribed, and paid-up capital will reduce from 111,976,150 shares to 110,582,150 shares. Promoters and persons in control are excluded from participating in the buyback; their shares will remain frozen at the ISIN level from August 8, 2026, until the buyback closes.

Category Pre Buyback Shares Pre Buyback % Post Buyback Shares Post Buyback %
Promoter and Promoter Group 48,419,510 43.24 48,419,510 43.79
Public Shareholders 63,556,640 56.76 62,162,640 56.21
Total 111,976,150 100.00 110,582,150 100.00

Financial Health and Rationale

The buyback is underpinned by strong financial performance. For Q1 FY27 (ended June 30, 2026), the company reported Revenue from Operations of ₹1,158.57 million and Profit After Tax of ₹223.46 million. In FY2026, Revenue from Operations stood at ₹4,527.66 million with a PAT of ₹1,318.06 million.

The Board confirmed that the company has no subsisting defaults in repayment of deposits, debentures, preference shares, dividends, or term loans. A cash escrow of ₹174,250,000 (25% of Maximum Buyback Size) has been deposited with HDFC Bank Limited. Emkay Global Financial Services Limited serves as the Manager to the Buyback, while MUFG Intime India Private Limited is the Registrar. The process complies with Regulation 5(vii) of the SEBI (Buy-back of Securities) Regulations, 2018, and relevant provisions of the Companies Act, 2013.

Historical Stock Returns for Advanced Enzyme Tech

1 Day5 Days1 Month6 Months1 Year5 Years
+0.09%-3.81%-5.32%+4.59%-16.53%-26.17%

Will Advanced Enzyme Technologies accelerate its daily buyback volume to meet the mandatory ₹278.8 million initial deployment target before the offer period's midpoint?

How might the substantial premium of the ₹500 buyback price over current market levels influence short-term trading volume and retail investor sentiment on the NSE?

Given that promoters are excluded from participation, what impact will the reduction in public float have on the stock's liquidity and volatility post-buyback?

More News on Advanced Enzyme Tech

1 Year Returns:-16.53%